Background Primary health care (PHC) is a driving force for advancing towards universal health coverage (UHC). PHC-oriented health systems bring enormous benefits but require substantial financial investments. Here, we aim to present measures for PHC investments and project the associated resource needs.
Introduction
Primary health care (PHC) is globally acknowledged as an essential driving force for advancing universal health coverage (UHC) and the 2030 Agenda for Sustainable Development. 1 Investing in PHC yields high returns and promotes sustainability. 2 Yet, only half of government spending in health across low-income and middle-income countries (LMICs) is currently allocated to primary care and public health interventions-ie, PHC services. 3 Ensuring quality PHC services should not be considered a low-cost strategy: investing in accessible health systems that provide a comprehensive set of interventions to all those in need can bring enormous benefits but will require significant financial investments. Among the commitments made at the Global Conference on Primary Health Care in October, 2018, countries and other stakeholders pledged to ensure adequate financing of primary health care in the Declaration of Astana. 4 The definition of how much is adequate is subject to debate.
Questions around spending targets for PHC have been debated for decades. In 1986, Patel 5 suggested that advancing PHC across so-called developing countries would cost about 5% of gross domestic product (GDP). Because of the realisation that resources are constrained, some stakeholders opted for a more selective definition of PHC, emphasising a smaller set of highly cost-effective interventions. 6 The past 10 years have seen a revitalisation of support for a broader PHC agenda, in line with the original commitments in the Declaration of Alma-Ata, and its importance in achieving the health-related Sustainable Develop ment Goals (SDGs). The Primary Health Care Performance Initiative was established in 2015 to sup port measurement of PHC-related variables, with PHC expenditure per capita as one recommended indicator. 7 Estimates of current PHC expenditure range between US$15 and $60 per capita in LMICs, depending on the definition applied. 3 At the country level, information on current spending can be compared against needs-based targets and projected costs for expanding service delivery, to inform resource allocation decisions.
Global resource needs for the SDGs serve multiple purposes, including advancing our understanding of implementation strat egies or production functions, supporting resource mobilisation, and informing financing strategies. 8 Global PHC costs were estimated in a 2018 study based on a defined set of services delivered through selected platforms that serve as first point of contact. 9 Watkins and colleagues 9 thus estimated that total annual costs of delivering PHC interventions in lowincome countries and lower-middle-income countries, at 80% population coverage, would amount to $350 billion, or about $97 per capita (2016). However, their approach did not explicitly consider that different countries have different capacities for scale-up and did not provide details on the type of system investments needed.
To adequately plan and finance health systems, and in particular to strengthen their PHC orientation,
Research in context
Evidence before this study Although the role of primary health care (PHC) for health outcomes is widely acknowledged, substantial variation exists in health service models and packages among countries, and little work has been done to develop detailed definitions of what PHC encompasses. Similarly, as of yet, few global benchmarks have been proposed for health system investment to strengthen PHC. Several studies and initiatives have considered the resource implications of functioning PHC systems. For example, in 1986, Patel suggested that PHC costs across developing countries would amount to around 5% of gross domestic product, but also noted that PHC programmes are largely undefined in terms of their content. Although the policy debate and visibility of PHC has increased, the boundaries of PHC, as well as related budgetary needs, remain poorly conceptualised. The Primary Health Care Performance Initiative was established in 2015 to support measurement of PHC-related variables, with PHC expenditure per capita as one recommended indicator. Country scorecards were designed, with an intent to report current PHC expenditure using a standardised method but without identifying a target. At the global level, Watkins and colleagues estimated the total annual cost of providing essential PHC interventions across low-income countries and lower-middle-income countries at 80% population coverage to be about $350 billion, or about $97 per capita on average (in 2016 US$). Although global per capita estimates of service delivery are useful to provide a rough indication of spending needs, countries also need guidance on system requirements to expand PHC. Therefore, our study takes an ingredients-based approach to be able to identify the specific inputs needed to strengthen PHC across different country contexts.
Added value of this study
To the best of our knowledge we develop here, for the first time, three measures that relate to investments to strengthen PHC-orientation in health systems, identifying both specific interventions and health systems requirements. The added value of our study is that we discuss different measures of PHC costs; we specify the inputs required to strengthen PHC delivery across countries and estimate costs using country-specific data; we present and discuss related investment guide posts; and we add to the evidence base on the potential impact to be brought by investments in PHC as well as the affordability of delivering high-quality PHC across different settings.
Implications of all the available evidence
Defined service packages, emphasising primary care and public health services, as well as multisectoral actions with an impact on health, help inform the health investment agenda in low-income and middle-income countries. The results provide evidence on the likely cost drivers within countries seeking to expand their health service coverage by strengthening PHC, and an estimate of additional resource needs. Impact modelling indicates that significant health gains can be achieved by investing in primary care and public health and confirms the catalytic role that PHC can play in the universal health care and Sustainable Development Goals agendas. Although all three measures presented here are important for operationalising PHC, countries can assess which measure is most relevant for their specific dialogue around investments and monitoring purposes, and use this information to drive context-appropriate investments along a continuum of comprehensive PHC. governments need information on the specific health system investments required. Here, we add to the global evidence base by drawing on the framework for WHO's previously published price tag for the health SDG targets 10 and specifically identifying investments required for PHC across the health system building blocks. By using an ingredients-based approach we can allow for differentiated coverage targets across different categories of countries and identify the cost drivers for accelerating PHC implementation. Explicitly defined measures for PHC investment needs can be used to advocate for increased budget allocations.
Methods

Study design
This modelling study was done using data from 67 LMICs (appendix p 2). Three measures of PHC costs were developed using a functional definition that focuses on the purpose of PHC interventions, rather than where, how, or by whom they are delivered or were developed. This approach is consistent with others in the literature, such as the methodology used by WHO to estimate current PHC expenditure, based on the system of health accounts, which uses a functional classification of services provided to monitor PHC expenditure. 3 Another advantage of this approach is that the explicit definition of PHC interventions within a country's essential service package can be aligned with the prin ciple of progressive realisation of UHC (ie, increasing access to an expanding PHC intervention package over time). 11 Recognising the variation in PHC interventions among countries, we propose three measures of PHC, which represent a successive expansion of the scope of interventions (table 1). These three measures are consistent with global definitions of PHC as agreed at the Global Conference on Primary Health Care, which emphasised that the three components of PHC as primary care and essential public health functions are the core of integrated health services; multisectoral policies and actions; and empowered people and communities. 4 Given the variation in health service models and intervention packages among countries, little work has been done to develop benchmarks for health system investment to strengthen PHC. 12 
Health system strengthening
Health workforce Health workforce estimates are calculated for three categories: medical doctors, nurses or midwifes, and other. We use a bottom-up approach to estimate the full-time equivalent workers required to provide the defined package of PHC interventions, by country and by year. Bottom-up estimates were also calculated for the full SDG set of interventions and a relative share was subsequently estimated for PHC. The relative share was applied to the total number of health workers estimated to be required for the WHO SDG price tag, which was based on target population-density ratios. Using this approach, the estimated health worker cost for PHC is a proportion of the population-density-based cost as estimated in the SDG price tag.
Similar to M1, we calculate the share of health workers' time spent delivering PHC interventions within the context of the overall SDG price tag; under M2, the share is greater, because it includes more interventions than M1. In order to account for generalised inpatient care, we include an additional share of health worker time.
Same as M2
Infrastructure and equipment
The model includes costs for health centres, district hospitals, and provincial hospitals. The full costs of building, refurbishing, and maintaining health centres is attributed to PHC. For district hospitals and provincial hospitals, we include a percentage share of the cost required to construct, refurbish, and equip. The share is derived from national health accounts expenditure data on non-specialised outpatient care in low-income and middle-income countries (33% for district hospitals and 3% for provincial hospitals).
Similar to M1, we include the full cost of health centres. We increase the share of costs allocated to PHC from district hospitals to 81% to account for general (non-specialised) inpatient care, and similarly increase the share to 27% for provincial hospitals. Again, the shares are based on data from national health accounts.
Same as M2
Health information system
Costs for strengthening the health-facility-based system Costs include components related to strengthening the health-facility-based system, administrative information systems, public health institutes, and administration of surveys the definitions used within the system of health accounts to differentiate between specialised and non-specialised (general) care health services. 13 The list of interventions included in each measure was further informed by an expert meeting and country validation process. Measure 1 includes preventive public health interventions and general outpatient services, and is thus largely consistent with the measure put forth for monitoring current expen diture as per the national health accounts framework. 3 Measure 2 broadens the scope of interventions by including non-specialised inpatient services, including uncomplicated deliveries and immediate neonatal care; it also captures a broader range of costs related to supportive health systems and health security, including compliance with the international health regulations. 14 Measure 3 goes further in capturing broader cross-sectoral investments that are important for health outcomes, such as water and sanitation, air quality improvements, road safety, and food safety, as well as broader health security (including animal health and zoonotic disease control). Specialised care, however, whether outpatient or inpatient, is excluded from all three measures. Cross-sectoral investments as included under measure 3-eg, investments to address respiratory, food-borne and water-borne diseases-play a key role that has been clearly established in the literature, and roughly a quarter of global disease burden could be prevented by reducing environmental risks. 15 Importantly, our measures delink interventions from the level of care, insofar as we include costs and effects for PHC interventions, even when they might be delivered at higher levels of care.
Applying PHC measures within a modelling framework
To apply these measures to an investment model, our starting point is WHO's cost projections for reaching the health SDG targets, published in 2017. 10 An explicitly defined set of essential health interventions (a health benefits package) and associated health system investments necessary to achieve the health-related SDGs were modelled to be scaled up from 2016 to 2030, across 67 LMICs. Within the model, countries are assumed to invest over time according to the maturity of their system, thereby progressing at different speeds according to their current system strength and capacity. The WHO 2017 model was largely limited to the health sector (table 2) .
The WHO SDG projection model was designed with a PHC-centred approach in mind-ie, the health workforce and infrastructure models were set up to accommodate a close-to-client health system, which makes it appropriate for our analysis. However, the model focuses on health sector investments, which limits the completeness of resource needs for measure 3, which go beyond the health sector. The original SDG model included 188 specific health interventions. These were established either to be PHC interventions or not, according to their classification within the health accounts framework. All interventions delivered through population or outreach platforms were included in one or more PHC measures, as were most clinical services (appendix pp 7-18). Shared investments required across the health system were estimated for the different health system building blocks as defined by WHO. Here, we used a mix of methods, in which some allocation rules were adopted from the expenditure monitoring frame work (eg, governancerelated costs) and others were derived from the PHCrelevant share of overall service delivery estimated within the WHO SDG projection model (eg, the share of health workforce and supply chain costs for PHC services as a share of the full modelled package of interventions). To the extent possible, health system investments are directly related to the package of interventions considered under each measure. Costs are estimated by country and by year using an ingredients-based approach-ie, breaking each investment down into a multiplication of quantities (by year) by prices, and using country-specific prices when available (appendix p 5).
The baseline year in our model is 2015, with investments scaled up successively until 2030. Our estimates are thus incremental to the assumed 2015 investment levels, and we assume limited progress was made during 2015-19. 16 Capital investment costs originally modelled for 2016-19 were redistributed to years 2020-30.
Here, we present incremental outputs for 2020-30. Similar to the previously published SDG projections, we present estimates for eight groups of countries: three income categories and five additional country categories representing different degrees of health system maturity 18 NTDs, 19 and stillbirths avoided. 10
Validation process
The approach to define PHC measures was discussed with country representatives and global health policy and modelling experts in a meeting in Geneva on Sept 24-27, 2018 . Participants included inter national experts and academics, as well as representatives from 12 LMICs whose population jointly accounts for more than 48% of the population in the 67 countries covered in the model. Country-specific data inputs used for the modelling were reviewed and validated by country par ticipants during the meeting, as well as through follow-up correspondence. Data were provided by country participants for the most recent year available.
Developing PHC investment guide posts
Investment guide posts are derived from our model for costs, outpatient visits, and health workforce. The estimates are generated by country-specific models but are aggregated and presented as average estimates by income level and country type. Guide posts are a partial measure, covering only the modelled interventions.
Here, we present them as conceptual measures for future assessment and monitoring purposes. Projected costs for PHC are presented as additional and total per capita estimates (panel). The additional amounts represent what is required to advance health service delivery beyond current levels of investment, assuming that current levels of investment remain at a constant level.
Projecting additional financing for PHC
We generate scenarios for expanding current health expenditure across all LMICs, considering three possible scenarios for growth in spending: business as usual (following the historical trend of each country); progress of 1% (achieving a 1% point increase in current health expenditure as a percentage of GDP), and an ambitious 2% (achieving a 2% point increase in current health expenditure as a percentage of GDP). To assess the potential financing gap, we calculated incremental costs and compared them with projected health spending and the share these costs would have of overall government expenditure and GDP in each country (appendix pp 37-42).
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
Estimated additional investment needs for PHC range from $200 billion for measure 1 to $253 billion for
Panel: Constructing investment guide posts for total primary health care (PHC) expenditure
Total PHC cost per capita is calculated as the sum of estimated current PHC expenditure plus the additional amount estimated through our analysis. Current PHC expenditure is estimated by applying option 5 from van de Maele and colleagues, 3 which includes general outpatient care, medical goods, and a share of administration costs. Data on current spending was available from WHO's global health expenditure database in 2016 US$ for 45 low-income and middle-income countries. We deflated estimates to 2014 US$ using country-specific price deflators. Results are presented as population-weighted average values by country group.
Expenditure estimates on PHC from health accounts only include recurrent expenditures, since expenditure on capital goods is reported separately within health accounts and no proposed methods exist for separating out the PHC share of capital investments. 11 Therefore, our investment guide posts for total PHC expenditure per capita are underestimated, because current expenditure is limited to recurrent costs only. Given the important role of investment in health infrastructure and equipment to improve geographical accessibility and quality of care, we advocate for future measures to include more complete reporting on capital expenditure for PHC. Estimates for workforce and visits differ across income groups because of differing starting points (existing numbers of health workers and patient contacts are higher in middle-income countries), to which we add the required numbers of workers and visits on the basis of country-specific epidemiology and coverage targets (ie, a high untreated non-communicable disease [NCD] prevalence in many middle-income countries increases the need for outpatient visits and workforce). Examining the incremental outpatient visits for modelled PHC interventions shows that the highest additional need is in low-income countries (4·0 per year).
Our projection model for financing indicates that if current trends continue, health expenditure across the 67 countries would increase from an average of 5·6% of GDP in 2016 to reach 6·1% of GDP in 2020 and 6·6% of GDP in 2030. However, by 2030, incremental PHC costs for measure 1 would on average require 3·3% of projected GDP (median 1·7% range 0·1-20·2; appendix pp 40-41). In a business-as-usual scenario, the number of countries with funding gaps would be 25 of 67 in 2030 ( figure 2 ). If funding for PHC was increased by 1-2% of GDP across Increasing coverage of PHC interventions in measure 1 during 2020-30 would avert an estimated 60·1 million deaths. Inclusion of skilled care at birth (ie, measure 2) allows us to report additional maternal (1·3 million for measure 1 vs 1·5 million for measure 2 and measure 3) and neonatal (9·7 million for measure 1 vs 11·1 million for measure 2 and measure 3) lives saved, whereas inclusion of cross-sectoral interventions (ie, measure 3) within our model increases the projected number of post-neonatal deaths averted (7·7 million for measure 1 and measure 2 vs 8·4 million for measure 3; table 4). With measure 1, life expectancy would increase by an average of 6·7 years in low-income countries, 4·0 years in lower-middle-income countries and 2·3 years in uppermiddle-income countries, using population-weighted averages (table 3) . As well as increasing life expectancy, the over all health of the population will also improve, with 396 million additional healthy years of life during 2020-30 ( figure 3 ). Most gains from PHC (for measure 1) fall within reproductive, maternal, neonatal, and child health. About three-quarters of averted stillbirths, neonatal deaths, and maternal deaths from PHC interventions are estimated to be derived from expanding access to family planning, thus reducing unplanned pregnancies and related mortality (appendix p 30). Significant gains stand to also be made for NCDs. Gains would be even greater for measure 2 and measure 3 (data not shown).
Discussion
We have presented a range of measures for PHC investment and estimated associated resource needs. According to our model, advancing a core set of PHC interventions in the health sector (measure 1) would require an additional $200 billion per year between 2020 and 2030 in LMICs. Expanding PHC towards a greater scope as outlined in the Declaration of Astana (ie, measure 3) would require at least $328 billion per year-and probably more.
Explicit intervention-based and input-based operational interpretations of PHC can help inform the investment agenda in LMICs. Others have previously investigated tiered models for PHC expenditure. 20 Our approach does not imply any successive ordering of interventions because many interventions are included under measure 2 and measure 3 that bring significant health benefits and are highly cost-effective.
Countries might find that one or more measures respond more closely to their policy context. During the validation process, although country participants expressed support for having multiple measures, most global experts supported measure 1 for universal assessment, with the main reason being that measure 1 is consistent with the current PHC expenditure methods. 3 This consistency allows a country to establish investment costs and to compare this against current expenditure. Although measures 2 and 3 are aligned with a broader interpretation of PHC in the 21st century, 12 the absence of agreed methods for reporting expenditure for these measures limits such a comparison of projected costs and reported current spending. Nevertheless, policy should not be limited by what can be measured, and forecasted investment needs for the full scope of PHC will be essential in all countries. Although our analysis is limited by insufficient models for projecting many crosssectoral investments in measure 3 that go beyond the scope of the original published SDG price tag analysis, within the current global programme of work, 21 WHO is supporting the development of models to address additional PHC interventions and cross-sectoral issues to broaden future analytical scope. Our estimates for the health SDG targets and for the subset of PHC compare in magnitude with global costs for other sectors, such as education (SDG 4), with costs estimated at 8·5% of GDP for LMICs. 22 Although our totals, and relative additional per capita needs, give an overall impression of what remains to be done, resource needs vary across countries, depending on current and future health burdens, and the strength and structure of health systems. What is clear is that major investments need to go into system strengthening, with health workforce and infrastructure development jointly accounting for 53-66% of additional costs within the three PHC measures (appendix p 49).
The results provide evidence on likely cost drivers for PHC and shed light on the premise of affordability across countries. Expanding PHC for all requires an adequate workforce that is well motivated, well resourced, and available where needed, with accessible infrastructure and functioning equipment. We show how health workforces need to increase from 5·6 per 1000 population to 6·7 per 1000 population to support basic functioning PHC systems (measure 1). In low-income countries, this would require an ambitious four-fold increase from a current level of 1·4 health workers per 1000 to 5·9 per 1000. Strengthening health systems and scaling up services under measure 1 would require on average an additional 3·3% of GDP for PHC by 2030. In terms of financing, in a business-as-usual scenario, projected current health expenditure across the 67 countries would increase from an average of 6·1% of GDP in 2020 to 6·6% of GDP in 2030. However, countries with the smallest GDP require the largest incremental investments. Even with a 1% GDP increased allocation towards PHC, almost 25 countries would not reach the modelled benchmarks, which is unfortunate because PHC can be a remarkably efficient and highly equitable investment. 23 Our analysis indicates that notable health gains can be achieved by investing in PHC, with up to 6·7 years gained in life expectancy in just an 11-year timeframe. For an extra $32 per capita, these health improvements have substantial value in themselves, but will also result in improved economic productivity and overall human capital. 24 Furthermore, research shows that PHC is associated with more appropriate, effective, and less costly care. 23 Thus, in theory, resource savings could potentially arise if countries reorient their systems towards PHC (eg, shifting services from tertiary or inpatient care to primary level or outpatient care). Our model does not take into account such shifts, because this kind of contextualised analysis would require in-depth country studies.
The impact modelling confirms the catalytic role that PHC can play for the UHC and SDG agenda. Most interventions within the SDG price tag were classified as PHC, which is consistent with Watkins and colleagues, 9 who classified 198 of 218 essential UHC interventions as PHC. Almost 75% of the health gain previously estimated as part of the SDG agenda 10 can be achieved through investing in PHC interventions under measure 1, with the caveat that many high-burden diseases, such as hepatitis, neurological and musculoskeletal disorders, and most cancers were not included in the impact analysis for the original SDG price tag on which the PHC-specific analysis draws. Subsequent work to expand the scope has since been done or is ongoing, 25 and can be incorporated into future updates of PHC resource needs. Measures 2 and 3 would bring substantially larger gains. However, the current projection model is limited in terms of cross-sectoral interventions and does not calculate deaths averted from investing in other sectors (aside from water and sanitation).
Importantly, even the narrower measure 1 includes comprehensive services across disease burden and life course needs as relevant to the SDGs; this diff erentiates the current service-oriented approach from previous models of selective PHC, which made some significant health gains, but fell short of the vision of PHC in the Declaration of Alma-Ata. The PHC investment guide posts were derived from a specific set of interventions within a pre-existing model, 10 and as such do not cover the full scope of interventions defined as PHC across all country contexts. For example, the 2017 SDG projections do not include interventions for rehabilitative care or long-term home-based care. Additionally, common conditions for care seeking in LMICs include musculoskeletal complaints and endocrine, digestive system, and skin complaints, 26 which are not explicit within our model. WHO is engaging in work to create a repository for UHC interventions, and this forthcoming work will serve to improve standardisation of information on WHOrecommended interventions, further advancing discussions around PHC. The boundaries within our model suggest that our guide posts are conservative estimates. Our model generates an average of 5·9 annual outpatient visits whereas the reported number of outpatient contacts per person per year in EU countries is 7·6. 27 Similarly, our estimated PHC commodity costs per capita includes only a subset of interventions and assumes the use of low-cost generic medicines, whereas in reality, budget requests for medicines might be much larger. Moreover, we have estimated the investment needs from the supply side. Once functional capacities are in place, the quality of care delivered needs careful attention, including clinical effectiveness, comprehensiveness of care, and interpersonal quality of care. 1, 28 Another weakness is our assumption that baselines changed little between 2015 and 2019, which might underestimate the baseline, and thus overestimate incremental resource needs. To address this, during the country consultation process we collected the most recent data for health infrastructure, health workforce, current population service coverage, and other important parameters, for inclusion in the model.
Despite the above challenges, the proposed PHC measures and investment guide posts are a conceptual framework for advancing discussions around investments in PHC. Global advocates for PHC can add more specificity to arguments for investment but in doing so should recognise that the guide posts are average estimates across countries, and as such should not be taken as absolute benchmarks for spending or health system maturity at the country level. Country policy makers can apply existing models to a locally defined PHC package and estimate resource needs. Civil society organisations can push for transparent budget allocation and benefit packages for PHC. The global community should strengthen existing evidence on recurrent and capital expenditures on PHC, advocate for targeted donor support to countries most in need, and support countries to prioritise within limited budgets.
Through our development of PHC investment guide posts we present an approach for measuring and projecting PHC investment needs in the context of advancing the UHC agenda towards the health-related SDGs. All countries should identify their own locally relevant policies for PHC, establish priority investments and associated reforms, and assess the costs and budgetary implications of these. In doing so, our approach provides a reference. Recommendations for future work include expanded models for cross-sectoral analysis, as well as projections for a more comprehensive package of health services.
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